Apyx medical sees q1 2020 revenue between $5 million to $5.6 million

Oration reports fourth quarter and full year of 2019 preliminary unaudited financial results and introduces first quarter of fiscal year 2020 financial outlook.q4 loss per share $0.16 from continuing operations.q4 revenue $8.4 million versus refinitiv ibes estimate of $7.9 million.sees q1 2020 revenue $5.0 million to $5.6 million.sees q1 2020 revenue down 0 to 11 percent.q4 earnings per share estimate $-0.19 -- refinitiv ibes data.q1 revenue view $7.8 million -- refinitiv ibes data.sees q1 gaap net loss in the range of $9.0 million to $8.6 million.
APYX Ratings Summary
APYX Quant Ranking